Article
High resolution deep mutational scanning of the melanocortin-4 receptor enables target characterization for drug discovery
2024-10-12
Abstract excerpt
Deep Mutational Scanning (DMS) is an emerging method to systematically test the functional consequences of thousands of sequence changes to a protein target in a single experiment. Because of its utility in interpreting both human variant effects and protein structure-function relationships, it holds substantial promise to improve drug discovery and clinical development. However, applications in this domain requir...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b5be85c3-37d0-55d5-b86a-23e5d91bda37
- DOI
- 10.1101/2024.10.11.617882
